CAPOZIDE 50/25 Drug Patent Profile

✉ Email this page to a colleague

When do Capozide 50/25 patents expire, and what generic alternatives are available?

Capozide 50/25 is a drug marketed by Apothecon and is included in one NDA.

The generic ingredient in CAPOZIDE 50/25 is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Capozide 50/25

A generic version of CAPOZIDE 50/25 was approved as captopril; hydrochlorothiazide by RISING on December 29^th, 1997.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CAPOZIDE 50/25?
What are the global sales for CAPOZIDE 50/25?
What is Average Wholesale Price for CAPOZIDE 50/25?

Summary for CAPOZIDE 50/25

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	13
Clinical Trials:	1
Patent Applications:	9
Formulation / Manufacturing:	see details
DailyMed Link:	CAPOZIDE 50/25 at DailyMed

Drug patent expirations by year for CAPOZIDE 50/25

Recent Clinical Trials for CAPOZIDE 50/25

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GlaxoSmithKline	Phase 1

See all CAPOZIDE 50/25 clinical trials

US Patents and Regulatory Information for CAPOZIDE 50/25

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apothecon	CAPOZIDE 50/25	captopril; hydrochlorothiazide	TABLET;ORAL	018709-003	Oct 12, 1984		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CAPOZIDE 50/25

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Apothecon	CAPOZIDE 50/25	captopril; hydrochlorothiazide	TABLET;ORAL	018709-003	Oct 12, 1984	⤷ Sign Up	⤷ Sign Up
Apothecon	CAPOZIDE 50/25	captopril; hydrochlorothiazide	TABLET;ORAL	018709-003	Oct 12, 1984	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CAPOZIDE 50/25

See the table below for patents covering CAPOZIDE 50/25 around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	1078385	COMPOSES DE 6-OXA-1-AZATRICYCLODECAN-5-ONE (1,4-ETHANO-6-OXO-OCTAHYDRO-QUINOLINE AND 6-OXA-1-AZA TRICYCLODODECAN-5-ONE COMPOUNDS)	⤷ Sign Up
Sweden	7901316		⤷ Sign Up
Argentina	213184	PROCEDIMIENTO PARA PREPARAR DERIVADOS DE 1,4-ETAN-6-OXO-PERHIDROQUINOLEINA Y SUS SALES	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for CAPOZIDE 50/25

Recent Clinical Trials for CAPOZIDE 50/25

Make Better Decisions: Try a trial or see plans & pricing